Physician profile
Michael Stott
NPI 1235581281
$6,830.47
in general payments reported to CMS, 2019-2025
25 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what 86% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,020 · 2020: $13.00 · 2021: $1,285 · 2022: $1,277 · 2023: $141 · 2024: $609 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Travel and Lodging: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.40 |
| Travel and Lodging | $1,101.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $3,967.10 | 2019-2022 | |
| Treace Medical Concepts, INC. | $1,876.20 | 2024-2025 | |
| Smith+Nephew, INC. | $227.85 | 2019-2024 | Collagenase Santyl |
| Pacira Pharmaceuticals Incorporated | $112.37 | 2019 | |
| Integra Lifesciences Corporation | $110.84 | 2019 | |
| Horizon Therapeutics Plc | $51.46 | 2022-2023 | Krystexxa |
| Linvatec Corporation | $50.38 | 2021-2025 | Biobrace 23mm, Neospan, Colink Plating System |
| Amgen INC. | $41.38 | 2024-2025 | Krystexxa |
| Tactile Systems Technology INC | $36.79 | 2025 | Flexitouch Plus, Nimbl |
| Abbvie INC. | $33.68 | 2023 | Dalvance |
| Alfasigma USA, INC. | $31.22 | 2021 | |
| Djo, LLC | $30.50 | 2019 | |
| Tersera Therapeutics LLC | $30.48 | 2019 | |
| Paratek Pharmaceuticals, INC. | $28.68 | 2025 | Nuzyra |
| Acera Surgical, INC. | $28.41 | 2025 | Restrata Wound Matrix |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $26.35 | 2025 | |
| Bioventus LLC | $22.10 | 2019 | |
| Mimedx Group, INC. | $20.61 | 2025 | |
| Abbott Laboratories | $18.96 | 2023 | Proclaim |
| Globus Medical, INC. | $17.23 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $15.29 | 2023 | |
| Sanofi-Aventis U.S. LLC | $14.52 | 2019 | |
| Sebela Pharmaceuticals INC. | $13.24 | 2021 | |
| Zimmer Biomet Holdings, INC. | $12.73 | 2019 | |
| Baudax Bio INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.